Durable local responses with subtherapeutic doses of concurrent radiation and gemcitabine in a patient with refractory Hodgkin's disease.
Halepota
Maqbool
M
Division of Hematology/Oncology, University of Kentucky, 800 Rose Street, Lexington, KY 40536, USA. mhalepota@hotmail.com
Mohiuddin
Mohammed
M
Desimone
Philip
P
Ahmed
Mansoor M
MM
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine